Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1994-08-22
1998-11-03
Achutamurthy, Ponnathapura
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
435 5, 435 691, 530413, 536 2353, 536 242, C07K 1600, C12Q 170, C12P 2106, A23J 100
Patent
active
058310347
ABSTRACT:
Novel human monoclonal anti-HIV-I antibodies and immunochemicals made from the antibodies and method of treating or preventing HIV-I infections.
REFERENCES:
patent: 5087557 (1992-02-01), McClure
Fahey, et al., Status of immune-based therapies in HIV infection and AIDS, Clin. exp. Immunol., 88, 1-5, see p. 3, second column, third full paragraph, Jan. 1992.
Buchacher Andrea
Jungbauer Alois
Katinger Hermann
Steindl Franz
Achutamurthy Ponnathapura
Katinger Hermann
Park Hankyel T.
LandOfFree
Human monoclonal anti-HIV-I-antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human monoclonal anti-HIV-I-antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human monoclonal anti-HIV-I-antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-690512